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Background: Cryptococcal meningoencephalitis (CM) is the most common opportunistic infection of the central
nervous system (CNS). Despite this observation, there have only been a few studies analyzing clinical characteristics
as well as cerebrospinal fluid (CSF), electroencephalograph (EEG), and magnetic resonance imaging (MRI) features in
CM patients of all ages.
Methods: We reviewed the medical records of all patients diagnosed with cryptococcal meningoencephalitis from
1998 to 2013 in the Nanfang Hospital in China and gathered data on the underlying diseases, bird exposure history,
and clinical features, including those from CSF, EEG and MRI.
Results: CM is more likely to infect adults younger than 60 years old. 71.3% of CM patients were male. Unlike data
from other countries, we found that chronic use of corticosteroids or other immunosuppressants (17.59%) was the
most frequent risk factor in CM patients rather than HIV infection (1.85%). Clear exposure with bird/ bird droppings
before CM onset is obvious in a previous study in CM children. However, our study found that 4.63% CM patients
had such an exposure. More importantly, patients with brain tissue damage (p = 0.021) and decreased CSF/blood
glucose ratio (p = 0.008) were significantly associated with death, but only the decreased CSF/blood glucose ratio
was the contributing factor of prognosis (odds ratio, 0.047; p = 0.025). Decreased CSF/blood glucose ratio was
significantly related to the survival length of CM (odds ratio, 0.134; p = 0.033).
Conclusions: Our study shows that CM has predilection for young male adults. The chronic use of corticosteroids
or other immunosuppressants, rather than HIV infection or bird/bird droppings exposure, was the most frequent
risk factor in CM patients in our study. Decreased CSF/blood glucose ratio was both an independent contributing
factor to death and was significantly related to the survival length of CM patients. The more decreased the
CSF/blood glucose ratio was, the worse prognosis and shorter survival length CM patients had.
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Cryptococcus neoformans can infect almost all organs in
the human body, but the infection site of serious conse-
quence is the central nervous system (CNS) [1-3]. Crypto-
coccus is the most common disease causing agent of the
CNS in not only HIV-positive patients and HIV-negative
patients undergoing various immunosuppressive regi-
mens, but also immunocompetent patients [4-8].
Unlike data collected from North America [9,10],
South America [7,8], Europe [11] and other countries in
Asia [5,6,12], the incidence of cryptococcosis in im-
munocompetent patients is high in China. Chen et al.
[1] had summarized some features of cryptococcosis in
China, but their focus was towards therapy. Guo [13],
on the other hand, found that the cerebrospinal fluid
(CSF) of children with cryptococcal meningoencephalitis
(CM) has particular characteristics but these characteris-
tics cannot be generalized for all other age groups. Here,
we collected the epidemiological and clinical characteris-
tics, including analysis of CSF, electroencephalograph
(EEG), and magnetic resonance imaging (MRI) features
of both children and adult CM patients from Nanfang
Hospital. The collected data was used to analyze special
characteristics of CM in the southern part of China. In
addition, we attempt to elucidate the independent con-
tributing factors for the prognosis, in hopes to stream-
line the decision of the appropriate CM therapy.
Methods
Data source and study population
Over a period from July 1, 1998 to June 30, 2013 (15 years),
108 patients from 11 months to 81 years of age at the
Nanfang Hospital were retrospectively identified as having
CM. Written approval for this study was obtained from
the ethics committee of the Nanfang Hospital. All patients
or their family members signed a written consent in ac-
cordance with the ethical committee standards during
their hospital stay or outpatient follow-up. In the present
study, the underlying diseases, bird exposure history, clin-
ical features, including CSF, EEGs and MRI of CM pa-
tients were shown and the probable contributing factors
for death and survival length were analyzed.
Study criteria
CM was diagnosed by either of the following methods:
(1) isolation of cryptococcus from previous or current
cerebrospinal fluid cultures, followed by a positive CSF
cryptococcal antibody, positive CSF India ink staining,
or positive CSF Aley new blue dye staining and clinical
features of meningoencephalitis; or (2) isolation of cryp-
tococcus in blood culture with clinical presentations of
meningoencephalitis and typical CSF features [10].
Patients were regarded as “with apparent risk factors”
when they have HIV infection, malignancies, cirrhosis,organ transplantation, end-stage renal failure autoimmune
disorder, diabetes mellitus, idiopathic CH4 T-cell lympho-
penia, sarcoidosis, chronic usage of corticosteroids or
other immunosuppressive therapy [14], and any abnormal
status (e.g. SLE and other systemic autoimmune diseases,
chronic kidney diseases, pregnant, mycosis infection of
other system, drug addiction, etc.).
The MRI features of CM were diagnosed by the fol-
lowing standard. Cerebral ischemic stroke was defined
according to the WHO criteria [15], and Bubble sign
was as follows [16]: lesions frequently seen in the basal
ganglia, thalami, and midbrain, hyperintensity on T2-
weighted images and fluid attenuated inversion recovery
(FLAIR) images without contrast enhancement.
Therapy
The 108 patients received treatment with an intravenous
administration of amphotericin B deoxycholate (AmBd),
which was given at 0.1 mg/kg the first day, 0.5 mg/kg the
second day and was increased to 1 mg/kg per day from the
third day, together with an oral 5-fluorocytosine (5-FC) at
100 mg/kg per day and fluconazole (FCZ) at 400 mg per
day, when they were diagnosed with CM. After 4–6 weeks
of treatment, if cryptococcus was no longer present in at
least three sequential CSF examinations by microscopy, we
stopped AmB. We continued to use FCZ and 5-FC for 6–9
more months. The patients with persistent high intracra-
nial pressure received a lumber puncture every 2 or 3 days
to relieve their symptoms.
Data analysis
Data was analyzed using SPSS 13.0 software. The cat-
egorical variables were performed by number (N)(%) and
the continuous variables by mean ± standard deviation
(SD). Chi-Square test was used to compare the categorical
variable, including gender, age, time interval from illness
onset to hospitalization, bird/ bird dropping exposure his-
tory and underlying diseases between patients recovered
and those dead, while independent sample t-test was used
to examine CSF protein, CSF glucose level and CSF/blood
glucose ratio. All variables with a p-value <0.10 on Chi-
Square test and t-test were included in a multivariate con-
ditional logistic regression model and a Cox regression
model to evaluate their independent effect and relation-
ship to survival length. Statistical significance was defined
as p < 0.05.
Results
The demographical characteristics
The demographical characteristics of 108 CM patients
collected during 15 years in the southern part of China
are shown in Table 1. Most of them were adults less
than 60 years old and 15 were children (including
18 years old) (Mean age 37.40 ± 17.69 years old; Range:
Table 1 Characteristics of patients of cryptococcal meningoencephalitis
Characteristic Recovered [no. (%)] see Dead [no. (%)] Lost# [no. (%)] Total p#
Age, years 49(45.37) 45(41.67) 14(12.96) 108 NS
0-10 2(1.85) 1(0.93) 2(1.85) 5
11-20 7(6.48) 6(5.56) 2(1.85) 15
21-30 6(5.56) 9(8.33) 4(3.70) 19
31-40 13(12.04) 10(9.26) 2(1.85) 25
41-50 8(7.41) 8(7.41) 2(1.85) 18
51-60 10(9.26) 3(2.78) 1(0.93) 14
61-70 2(1.85) 3(2.78) 1(0.93) 6
71-80 1(0.93) 4(3.70) 0(0) 5
81- 0(0) 1(0.93) 0(0) 1
Gender 49(45.37) 45(41.67) 14(12.96) 108 NS
Male 36(33.33) 30(27.78) 11(10.19) 77
Female 13(12.04) 15(13.89) 3(2.78) 31
Time interval from illness onset
to hospitalization (days)
49(45.37) 45(41.67) 14(12.96) 108 NS
1-10 9(8.33) 6(5.56) 1(0.93) 15
11-20 10(9.26) 13(12.04) 3(2.78) 25
21-30 13(12.04) 18(16.67) 5(4.63) 36
31- 17(15.74) 8(7.41) 5(4.63) 29
Underlying disease* 22(20.37) 21(19.44) 4(3.70) 47 NS
Exposure history 2(1.85) 3(2.78) 0(0) 5 NS
Brain tissue damaged** 9(8.33) 18(16.67) 4(3.70) 31 0.021
Laboratory findings
High intracranial pressure 43(39.81) 35(32.41) 13(12.04) 91 NS
Increased CSF protein 38(35.19) 31(28.70) 10(9.26) 79 NS
Decreased CSF glucose 26(24.07) 29(26.85) 9(8.33) 64 NS
Abnormal EEG*** 16(42.11) 9(23.68) 2(5.26) 27 NS
Abnormal MRI**** 20(41.67) 10(20.83) 4(8.33) 34 NS
*Underlying diseases included use of corticosteroids or other immunosuppressants 19 cases, SLE 8 cases, Tuberculosis 6 cases (1 with CNS infection and 5 with
lung infection), hematopathy 5 cases (2 with ITP, 1 with leukemia, 1 with NHL and 1 with AIHA), DM 5 cases, kidney diseases 4 cases (2 with renal failure, 1 with
nephrotic syndrome and 1 with RPGN), HIV 2 cases, organ (renal) transplantation 1 case, cancer (nasopharyngeal carcinoma) 1 case, hyperthyroidism 1 case,
pregnant 1 case, hepatitis B 1 case and mycotic infection 1 case.
**Brain tissue damage included altered consciousness 17 cases, seizures 6 cases, cerebellum symptoms 6 cases and mental disorders 4 cases. (Several cases with
more than one symptom).
***Abnormal EEG included normal background 20 cases (1 with epileptiform discharge and 19 with focal slow wave) and diffused slow wave in the background
7 cases.
****Abnormal MRI included Bubble sign 9 cases (6 at the basal ganglion and 3 at subcortex), hydrocephalus 16 cases, abnormal lesions 16 cases (8 cases with
hemilateral lesions, 8 cases with bilateral lesions) and ischemic lesions 3 cases (2 with ischemic lesion and 1 with transient ischemic attack) (most cases with more
than one abnormal features).
#NS, not significant (p > 0.05).
Zheng et al. BMC Infectious Diseases  (2015) 15:77 Page 3 of 711 months-81 years) (Table 1). Among the 108 patients, 77
(71.30%) were male and 31 (28.70%) were female. The
mean age of male and female were 38.95 ± 18.32 years and
33.55 ± 15.65 years old, respectively. Average time interval
from illness onset to hospitalization was 47.38 ± 72.33 days.
47 of 108 cases (43.52%) showed apparent risk factors. The
most common risk factor was chronic use of corticosteroids
or other immunosuppressants (17.59%), and systemic lupus
erythematosus (SLE) was found in 8 (7.41%) cases andtuberculosis in 6 (5.56%) cases (1 with a CNS infection and
5 with lung infection). Other risk factors contain hematopa-
thy (4.63%), diabetes mellitus (DM,4.63%), kidney diseases
(3.70%), HIV infection (1.85%), organ transplantation
(0.93%), nasopharyngeal carcinoma (0.93%), hyperthyroid-
ism (0.93%), pregnant (0.93%), hepatitis B infection (0.93%),
peptic ulcer (0.93%) and mycotic infection (0.93%). 5 cases
(4.63%) of 108 had clear exposure with bird/ bird droppings
before CM onset.
Table 2 mRS score of survival patients of cryptococcal
meningoencephalitis













0.3426 ± 0.16447 0.246 ± 0.17048 0.008
CSF glucose 2.1439 ± 1.13714 1.8089 ± 1.44314 NS
CSF protein 0.7937 ± 0.55197 0.7609 ± 0.50626 NS
#NS, not significant (p > 0.05).
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Nonspecific symptoms, such as headache (75.00%) and
fever (62.04%) were frequently found in CM patients.
However, symptoms associated with brain tissue damage
(17 with unconsciousness, 6 with seizures, 6 with cere-
bellum symptoms and 4 with psychosis) were also seen
(Table 1).
We collected the first CSF results of these 108 CM pa-
tients, and found that increased intracranial pressure
was the most common change (84.26%), including 72
cases higher than 30 cm H2O (seriously abnormal). In-
creased protein, decreased glucose, and decreased CSF/
blood glucose ratio were also apparent in CSF of CM
patients (Table 1).
38 (35.19%) of the 108 CM patients had EEG examina-
tions in our hospital and 11 (28.95%) were normal.
Among the abnormal EEG results, 1 (2.63%) had epilep-
tiform discharge, 7 (18.42%) with slow wave background
and 19 (50.00%) had normal background with diffused
slow wave.
48 (44.44%) patients had cranial MRI in or out of our
hospital and 34 of them had abnormal features. 9
(18.75%) of these cases had Bubble sign, 6 (12.50%) of
which were at basal ganglions and 3 (6.25%) at subcortex.
16 (33.33%) of the 48 cases had abnormal lesions at brain
hemisphere, including 8 (16.67%) bilateral and 8 (16.67%)
hemilateral. In addition, 16 (33.33%) cases had hydroceph-
alus and 3 patients (6.25%) had ischemic lesions.
Outcome
The median length of hospitalization was 41 days (range:
1–389 days), and the median survival length was
4.51 months (range: 0.03-160.68 months). According to
the follow up on Aug, 2013, 49 (45.37%) cases were re-
covered, 45 (41.67%) cases were dead of CM and 14
(12.96%) cases were lost due to discontinued communi-
cation (Table 1). The survival patients were scored ac-
cording to the modified Rankin Scale (mRS) when they
came to the hospital, and the latest mRS score of them
were shown in Table 2. 14 patients had no symptoms at
all; 21 mild symptoms or slight disability (10 scored 1
and 11 scored 2); 12 moderate disability (9 scored 3 and
3 patients scored 4), while 6 severe disability.
Contributing factors of death and survival length
Chi-Square test and independent sample t-test were used
to identify factors related to prognosis (Tables 1 and 3),
which indicated that patients with brain tissue damage
(p = 0.021) and decreased
CSF/blood glucose ratio (p = 0.008) were significantly
associated with death. Then multivariate logistic analysis
was performed to determine the independent contribut-
ing factors for death of CM (Table 4). Compared to pa-
tients with normal CSF/blood glucose ratio (1/2-2/3),others with decreased CSF/blood glucose ratio were
more likely to die than recover (Odds ratio(OR) = 0.047;
95%CI =0.003-0.685; p = 0.025).
Furthermore, we made use of Cox regression analysis of
CM patients (Table 5) and found decreased CSF/blood
glucose ratio was significantly related to the decreasing
survival length of CM patients(OR = 0.134; 95%CI = 0.021-
0.847; p = 0.033).
In summary, we demonstrated that decreased CSF/
blood glucose ratio and having brain tissue damage
symptoms were associated with prognosis in CM pa-
tients, but only decreased CSF/blood glucose ratio was
an independent contributing factor. Furthermore, CSF/
blood glucose ratio was significantly related to the sur-
vival length of CM. The more decreased the CSF/blood
glucose ratio was, the worse prognosis and shorter sur-
vival length CM patients had.
Discussion
In this study, we analyzed 108 patients diagnosed with
CM from Nanfang Hospital in the southern part of
China and identified some characteristics of CM from
them. Although CM may affect people of any age [17],
neonates, children and the elderly were not the predilec-
tion in our study, mostly because of their limited envir-
onmental exposure. In accordance with other studies
[12], male predominance (71.30%) was apparent in this
study, the reason of which was not fully understood, but
can be due to increased environmental exposure, hor-
monal effect and/or genetic predisposition [3].
Table 4 Multivariate conditional logistic analysis of risk
factors for prognosis of cryptococcal meningoencephalitis
patients




With Brain tissue damaged symptoms NS 2.252(0.841-6.032)
#NS, not significant (p > 0.05).
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Europe (68%) [7] and United States (89%) [4], 2 cases
(1.85%) were HIV positive in CM patients in our study.
Nevertheless, chronic use of corticosteroids or other im-
munosuppressants (17.59%) was the most common risk
factor in Chinese CM patients, probably as a result of
the increasing morbidity of autoimmune disease and less
attention of side effects of such drugs from patients and
care givers. Unlike the exposure history in HIV negative
children [13], there was fewer people who had bird/bird
dropping exposure in adults with CM.
Among nonspecific symptoms, the most common
symptoms were lower than reported by a previous study
by Chen, with obvious differences in headache (75.00%
vs. 90%) and fever (62.04% vs. 90%) [1]. Symptoms asso-
ciated with brain tissue damage, like unconsciousness,
seizures, cerebellum symptoms and psychosis were
fewer, which demonstrated the preferred location of CM
was meninges rather than brain parenchyma. Further-
more, cryptococcosis should be taken into consideration
when patients present with prolonged headache [18],
whether fever exists or not.
Most of the CM patients had abnormal EEG, but the
EEG results could not directly be attributed to diagnosis
of CM.
MRI had some features indicating probable cryptococcal
meningoencephalitis, which should be of particular interest.
The common imaging features of cryptococcal meningo-
encephalitis reported previously included non-enhancing
dilated Virchow-Robin space, gelatinous pseudocysts (bub-
ble signs), leptomeningeal enhancement, hydrocephalus,
cyptococcoma, hemorrhagic infarction, and abscess [18-20].
In our study, however, gelatinous pseudocysts (Bubble
signs) and hydrocephalus were the common ones. Al-
though gelatinous pseudocysts (18.75%) - which were sym-
metrically hyperintense on T2-weighted and FLAIR imagesTable 5 Cox regression analysis of risk factors for survival
length of cryptococcal meningoencephalitis patients
Risk factors p# OR (95% CI)
The ratio of CSF glucose/blood glucose 0.033 0.134(0.021-0.847)
With brain tissue damaged symptoms NS 1.562(0.829-2.942)
#NS, not significant (p > 0.05).in the basal ganglia, thalami and midbrain - did not appear
in each case, its appearance strongly pointed to cryptococ-
cus spreading along the Virchow–Robin spaces (VRS)
[16]. Hydrocephalus is another characteristic of crypto-
coccal meningoencephalitis, but only one third (33.33%)
of patients with MRI in this research presented this char-
acteristic, probably due to the early appearing high intra-
cranial pressure.
Cerebrospinal fluid is the most important examination
in the diagnosis of CNS infections including CM. Al-
though previous studies [18,19] mentioned increased
CSF pressure, increased protein and decreased glucose
level of the CSF, there has not been any detailed descrip-
tions about their changes. In our study, about 84.26%
patients had high intracranial pressure, 79.12% of which
were higher than 30 cm H2O. So far, there is no patho-
physiologic mechanisms about the change, but it can be
linked to impaired CSF reabsorption as a consequence
of a direct cryptococcal infiltration of the villi [21]. Re-
duced CSF outflow possibly resulting from an increased
outflow resistance - though not necessarily accompanied
by prominent cerebral edema [22] - can to some extent ex-
plain the ICP in cryptococcal meningoencephalitis. Inter-
estingly, from our analysis, patients with high CSF pressure
did not correlate to worse prognosis, as previously hypoth-
esized, probably because of a longer hospitalization period
resulting in increased attention from doctors and family
members. As a result of increased protein secretion stimu-
lated by cryptococcus and blockage of CSF circulation,
73.15% of 108 patients had increased CSF protein and
41.77% were more than 1 g/L. 64 cases (59.26%) of the 108
patients had decreased CSF glucose level, 32 of which had
lower than 1 mmol/L. In addition, patients with lower CSF
glucose level often had worse prognosis, probably because
low CSF glucose usually indicated high cryptococcus titer
and weak host immunity state. This mechanism can be our
future work of the CM study.
Darze [23] reported that consciousness level contributes
to CM prognosis, while other studies demonstrated a lower
CSF opening pressure and a change of white blood cell in
CSF was associated to a higher lethality rate [24]. In our
study, however, we analyzed both symptoms induced by
brain tissue damage, such as change of consciousness level,
epilepsy, cerebellum symptoms and psychosis, and CSF
changes in CM patients. We found that symptoms induced
by brain tissue damage were associated with prognosis, but
not an independent contributing factor. The decreased
CSF/blood glucose ratio was an independent contributing
factor for prognosis instead of a low CSF glucose level, a
change of CSF pressure, or a change of white blood cells in
CSF,. Patients with decreased CSF/blood glucose ratio were
unlikely to recover and inclined to die. Furthermore, CM
patients with decreased CSF/blood glucose ratio had signifi-
cantly shorter survival length.
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tributing factors for death and survival length of CM pa-
tients, there were some limitations in it. We followed up
with most of the CM patients, but some cases were lost
in the rural area and mountain region, which were diffi-
cult to either reach or contact by phone or mail. Prob-
ably due to this lost data, the result presented in our
survival curve (see Additional file 1) could not effectively
portray the changes between patients with decreased
CSF/blood glucose ratio and those with a normal ratio.
Improvement of follow-up methods may give us more
information. Scarcity of EEG and cranial MRI data col-
lected limited the potential of finding valuable clues of
CM. In addition, a larger sample size used in our study
may allow the probability to detect more contributing
factors for mortality and survival length, besides de-
creased CSF/blood glucose ratio and symptoms from
brain tissue damage. Continuous surveillance or a multi-
center study should be taken for a more detailed study.
Conclusions
CM is the most opportunistic infection of the CNS
worldwide. Our study showed some characteristics of
CM in the southern part of China. CM is more likely to
infect young adult rather than children and elderly, and
more likely to infect male rather than female. Chronic
use of corticosteroids or other immunosuppressants, ra-
ther than HIV infection, was the most frequent risk fac-
tor in CM patients in our study. Bird or bird dropping
exposure was not as important in the whole population as
in children. Decreased CSF/blood glucose ratio and pres-
ence of brain tissue damage symptoms were associated
with CM, but only decreased CSF/blood glucose ratio was
an independent contributing factor. Furthermore, CSF/
blood glucose ratio was significantly related to the survival
length of CM patients. The more decreased the CSF/blood
glucose ratio was, the worse prognosis and shorter survival
length CM patients had.Additional file
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